Bicara Therapeutics Cash Flow Statement (2023-2026) | BCAX

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -22.84M-12.44M-12.51M-17.05M-17.48M-20.96M-36.85M-27.39M-36.33M-37.39M-56.21M
Depreciation and Depletion (Quarter) 0.01M0.01M0.01M0.01M0.01M0.02M0.02M0.02M0.04M0.04M
Share-based Compensation (Quarter) 1.15M-1.15M7.40M3.45M3.49M3.61M-8.68M5.86M
Cash from Operations (Quarter) -8.04M-14.59M-12.91M-17.22M-30.03M-28.11M-25.59M-29.25M-23.89M-37.51M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) -0.27M-0.34M
Amortization of Deferred Charges (Quarter) 0.07M0.07M0.07M0.14M0.21M0.25M0.27M
Depreciation & Amortization (CF) (Quarter) 0.01M0.01M0.01M0.01M0.01M0.02M0.02M0.02M0.04M0.04M
Change in Working Capital
Change in Accured Expenses (Quarter) 4.20M0.41M-1.59M-1.19M9.00M3.28M-1.78M-0.27M1.57M11.72M
Other Working Capital Changes (Quarter) -0.04M-0.07M-0.07M-0.07M0.29M-0.15M-0.18M-0.32M-0.29M-0.27M
Investing Activities
Capital Expenditures (Quarter) 0.44M0.00M0.02M0.01M0.04M0.04M0.24M0.06M
Sales of Property, Plant and Equipment (Quarter) 0.06M
Change in Acquisitions & Divestments (Quarter) 101.00M
Cash from Investing Activities (Quarter) -0.44M0.06M-0.02M-0.01M-0.04M-236.12M-82.33M100.94M
Financing Activities
Other financing activities (Quarter) 0.14M1.33M0.06M0.08M0.46M0.14M0.44M1.73M1.58M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter) -1.05M29.50M161.76M
Misc.
Cash from Financing Activities (Quarter) 194.70M0.14M0.73M334.13M-0.97M0.46M0.14M0.44M31.23M163.34M
Change in Cash (Quarter) 186.23M-14.39M-12.19M316.90M-31.05M-27.65M-25.46M-264.93M-74.99M226.78M
Free Cash Flow (Quarter) -8.47M-14.59M-12.93M-17.23M-30.07M-28.11M-25.59M-29.29M-24.12M-37.57M
Net Cash Flow (Quarter) 186.23M-14.39M-12.19M316.90M-31.05M-27.65M-25.46M-264.93M-74.99M226.78M